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An increasedmortality risk is associated with acute renal failure
(ARF) complicating abdominal aortic aneurysm (AAA) repair re-
gardless of supportive therapy. Consequently, it is imperative to
select treatment options that minimize this complication. Wald
et al provide a well-conceived report that uses the Nationwide
Inpatient Sample (NIS) to compare the incidence of ARF associ-
ated with open AAA and endovascular aortic aneurysm repair
(EVAR). Many of the study weaknesses are acknowledged, and some
are addressed by the authors’ statistical analysis. However, the single
greatest weakness—limitations posed by the NIS database—cannot
be fully addressed.
The NIS is inadequate to account for critically important
cofounders relevant to the question of comparable ARF risk for
open AAA repair and EVAR. Patient-specific information pertain-
ing to aneurysm anatomy is not provided by the database. As a
result, no adjustments can be made for aneurysm location or
structure. An increased incidence of chronic lung disease and heart
failure among patients submitted to open AAA repair suggest that
procedure selection was made on the basis of anatomic criteria
favorable for EVAR. Selection bias for open repair may have
included juxtarenal/suprarenal AAAs with well-recognized risk
factors for ARF—suprarenal or extended aortic cross-clamp asso-
ciated with increased blood loss. Moreover, the NIS does not
provide patient-specific information regarding readmission for
ARF. The authors suggest that deterioration in renal function
secondary to contrast nephropathy with EVAR would be recog-ular filtration rate may not be detected among patients with
baseline serum creatinine within the normal range. In particular,
renal function decline due to atheroembolism may escape detec-
tion during this time frame.
The authors attempt to account for unmeasured confounding
covariates through generation of a propensity score for receipt of
EVAR. Although appropriate and useful, the propensity score
controls for only observed covariates.1 Only prospective random-
ization controls for both observed and unobserved covariates. In
this latter regard, the Dutch Randomized Endovascular Aneurysm
Management (DREAM) Trial Group observed an equal ARF risk
for open AAA repair and EVAR.2 Although this trial required
participating centers to have high volumes in both open AAA
repair and EVAR, it should be considered the best comparison of
relative renal risk associated with these procedures. Because of
uncorrectable residual confounding associated with selection and
information bias, the findings of this well-written article provide a
measure of reassurance regarding ARF risk associated with EVAR,
but the findings cannot be considered conclusive.
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Cohort assembly
Primary diagnosis code of unruptured abdominal aortic aneurysm (AAA):
441.4, abdominal aortic aneurysm without mention of rupture
AND
Primary procedure code of open AAA repair or endovascular repair of aortic aneurysm (EVAR):
38.44, resection of vessel with replacement (aorta, abdominal)
OR
39.71, endovascular implantation of graft in abdominal aorta
Excluded:
● concomitant renovascular surgery: 39.24 (aorta-renal bypass)
● patients with end-stage renal disease:
V45.1, renal dialysis status
V56.0, extracorporeal dialysis; dialysis (renal) not otherwise specified
V56.8, other dialysis; peritoneal dialysis
39.95, hemodialysis with chronic kidney disease (CKD) code but no concomitant code for acute renal failure (ARF) (see below for
ARF and CKD codes)
Outcomes
Acute renal failure:
584.5, acute renal failure with lesion of acute tubular necrosis
584.6, acute renal failure with lesion of renal cortical necrosis
584.7, acute renal failure with lesion of renal medullary (papillary) necrosis
584.8, acute renal failure with other specified pathological lesion in kidney
584.9, acute renal failure, unspecified
997.5, urinary complications of surgical care (including ARF due to procedure, acute renal insufficiency specified as due to
procedure, acute tubular necrosis specified as due to procedure)
Acute renal failure requiring hemodialysis:
ARF as above  procedure code for hemodialysis (39.95)
Comorbidities
Chronic kidney disease:
403.xx, hypertensive renal disease
404.xx, hypertensive heart and renal disease
581.xx, nephrotic syndrome
582.xx, chronic glomerulonephritis
583.xx, nephritis or nephropathy, not specified as acute or chronic
585, chronic renal failure, chronic uremia
586, renal failure, unspecified
593.9, unspecified disorder of kidney and ureter (includes renal disease (chronic) not otherwise specified)
Chronic liver disease:
070.22, chronic viral hepatitis B with hepatic coma
070.23, chronic viral hepatitis B with hepatitis delta with hepatic coma
070.32, chronic viral hepatitis B without mention of hepatic coma
070.33, chronic viral hepatitis B with hepatitis delta without mention of hepatic coma
070.44, chronic hepatitis C with hepatic coma
070.54, chronic hepatitis C without mention of hepatic coma
456.0, esophageal varices with bleeding
456.1, esophageal varices without mention of bleeding
456.20, esophageal varices in diseases classified elsewhere, with bleeding
456.21, esophageal varices in diseases classified elsewhere, without mention of bleeding
571.0, alcoholic fatty liver
571.2, alcoholic cirrhosis of liver
571.3, alcoholic liver damage, unspecified
571.40-571.49, chronic hepatitis (non-viral)
571.5, cirrhosis of liver without mention of alcohol
571.6, biliary cirrhosis
571.8, other chronic non-alcoholic liver disease
571.9, unspecified chronic liver disease without mention of alcohol
572.3, portal hypertension
572.8, other sequelae of chronic liver disease
V42.7, liver transplant
Chronic pulmonary disease:
490, bronchitis not specified as acute or chronic
491.xx, obstructive chronic bronchitis
492.x, emphysema
493.xx, asthma
494.x-, bronchiectasis
495.x, extrinsic allergic alveolitis
496, chronic airway obstruction, not elsewhere classified
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500, coal workers’ pneumoconiosis
501, asbestosis
502, pneumoconiosis due to other silica or silicates
503, pneumoconiosis due to other inorganic dust
504, pneumonopathy due to inhalation of other dust
505, pneumoconiosis unspecified
506.4, chronic respiratory conditions due to fumes or vapors
Congestive heart failure:
398.91, rheumatic heart failure (congestive)
402.01, malignant hypertensive heart disease with heart failure
402.11, benign hypertensive heart disease with heart failure
402.91, unspecified hypertensive heart disease with heart failure
404.01, malignant hypertensive heart and renal disease with heart failure
404.03, malignant hypertensive heart and renal disease with heart failure and renal failure
404.11, benign hypertensive heart and renal disease with heart failure
404.13, benign hypertensive heart and renal disease with heart failure and renal failure
404.91, unspecified hypertensive heart and renal disease with heart failure
404.93, unspecified hypertensive heart and renal disease with heart failure and renal failure
428.xx, heart failure
Diabetes mellitus:
250.xx, diabetes mellitus (with various complications)
